Long-term results of ENGAGE: a phase 3, randomized, double‑blind, placebo-controlled, multi‑center study investigating the efficacy and safety of eliglustat in adults with type 1 Gaucher disease.

Subjects

Subjects :

*GAUCHER'S disease treatment
*MEDICATION safety
*DRUG efficacy
*PLACEBOS
*RANDOMIZED controlled trials
DISEASES in adults

Details

Language :

English

ISSN :

10967192

Volume :

120

Issue :

1/2

Database :

Academic Search Index

Journal :

Molecular Genetics & Metabolism

Publication Type :

Academic Journal

Accession number :

121104525

Full Text :

https://doi.org/10.1016/j.ymgme.2016.11.243